We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: dermatology
MedXY News
EnglishTag

dermatology

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Equivalence of Online and In-Person Care in Managing Atopic Dermatitis: Insights from a Large Randomized Trial
Dermatologyatopic dermatitistelehealth

Equivalence of Online and In-Person Care in Managing Atopic Dermatitis: Insights from a Large Randomized Trial

By MedXY|Aug 27, 2026

A randomized clinical trial shows online team-based care is as effective as conventional in-person treatment for atopic dermatitis, offering an accessible alternative for chronic disease management.

A Practical Framework for Pyoderma Gangrenosum: Expert Consensus Defines Phenotypes and Modifiers
DermatologyConsensuspyoderma gangrenosum

A Practical Framework for Pyoderma Gangrenosum: Expert Consensus Defines Phenotypes and Modifiers

By MedXY|Aug 12, 2026

An expert Delphi panel established a standardized, descriptive classification for pyoderma gangrenosum (PG) to improve diagnosis, research, and treatment planning by defining distinct phenotypes and key disease modifiers.

Navigating Scrotal Health: A Comprehensive Guide to Lymphedema and Excessive Sweating
Dermatologydermatologymen's health

Navigating Scrotal Health: A Comprehensive Guide to Lymphedema and Excessive Sweating

By MedXY|Mar 8, 2026

This article provides an in-depth exploration of scrotal lymphedema and hyperhidrosis, detailing their physiological causes, clinical symptoms, and the latest management strategies for both patients and healthcare providers.

Pumecitinib 3% Gel Shows Robust Efficacy and Minimal Systemic Absorption in Mild-to-Moderate Atopic Dermatitis Treatment
Allergy & Immunologyatopic dermatitisdermatology

Pumecitinib 3% Gel Shows Robust Efficacy and Minimal Systemic Absorption in Mild-to-Moderate Atopic Dermatitis Treatment

By MedXY|Mar 5, 2026

A Phase IIb clinical trial demonstrates that pumecitinib 3% gel significantly improves skin clearance in adults with mild-to-moderate atopic dermatitis. Twice-daily application proved superior to once-daily dosing, maintaining a favorable s

Targeting CXCR1/2 Ligands: Eltrekibart Demonstrates Clinical Potential in Phase 2 Hidradenitis Suppurativa Trial
Dermatologydermatologyhidradenitis suppurativa

Targeting CXCR1/2 Ligands: Eltrekibart Demonstrates Clinical Potential in Phase 2 Hidradenitis Suppurativa Trial

By MedXY|Mar 5, 2026

A Phase 2 trial of eltrekibart, a novel monoclonal antibody targeting CXCR1/2 ligands, suggests high clinical efficacy in hidradenitis suppurativa. While frequentist analysis was neutral, Bayesian augmented models showed a 99.9% probability

Saturated Saline Immersion: A Novel and Noninvasive Approach for Refractory Plantar Warts
DermatologydermatologyHPV

Saturated Saline Immersion: A Novel and Noninvasive Approach for Refractory Plantar Warts

By MedXY|Mar 5, 2026

This report examines a clinical trial using 30-minute daily saturated saline immersion to treat refractory plantar warts, achieving an 88.2% complete remission rate without pain or recurrence.

Agent Orange Exposure and Acral Melanoma: Uncovering Non-Ultraviolet Risk Factors in the US Veteran Population
DermatologyAcral Melanomadermatology

Agent Orange Exposure and Acral Melanoma: Uncovering Non-Ultraviolet Risk Factors in the US Veteran Population

By MedXY|Feb 5, 2026

A large-scale study within the VA health system identifies Agent Orange exposure as a significant risk factor for acral melanoma, while highlighting distinct clinical profiles and a paradoxical inverse association with smoking compared to o

Dual-Action IgY and Cerium Oxide Nanofibrous Dressings Accelerate Scarless Healing in Infected Wound Models
Dermatologydermatologyimmunotherapy

Dual-Action IgY and Cerium Oxide Nanofibrous Dressings Accelerate Scarless Healing in Infected Wound Models

By MedXY|Jan 29, 2026

Researchers have developed a novel P/G@IYCe dressing combining yolk immunoglobulins and cerium oxide nanoparticles. This synergy effectively neutralizes bacterial pathogens and reactive oxygen species, facilitating rapid, high-quality skin

Selective TYK2 Inhibition in Atopic Dermatitis: Efficacy and Safety of ICP-332 in a Phase 2 Randomized Clinical Trial
Clinical Updatesatopic dermatitisclinical trials

Selective TYK2 Inhibition in Atopic Dermatitis: Efficacy and Safety of ICP-332 in a Phase 2 Randomized Clinical Trial

By MedXY|Jan 29, 2026

This review synthesizes findings from a Phase 2 trial of ICP-332, a novel TYK2 inhibitor, demonstrating significant EASI score improvements and a manageable safety profile in moderate to severe atopic dermatitis.

Rethinking Scabies Treatment: Why Permethrin Cream Still Leads Over Oral Ivermectin
Dermatologydermatologyivermectin

Rethinking Scabies Treatment: Why Permethrin Cream Still Leads Over Oral Ivermectin

By MedXY|Jan 21, 2026

A large-scale multicentre clinical trial reveals that 5% permethrin cream is significantly more effective than oral ivermectin for treating scabies in households, providing crucial evidence for public health and clinical practice.

Breaking the Cycle of Chronic Wounds: Prademagene Zamikeracel Sets New Standard for RDEB Treatment
Dermatologydermatologygene therapy

Breaking the Cycle of Chronic Wounds: Prademagene Zamikeracel Sets New Standard for RDEB Treatment

By MedXY|Jan 7, 2026

The Phase 3 VIITAL trial demonstrates that prademagene zamikeracel, an autologous gene-modified cellular sheet, significantly improves healing and reduces pain in patients with recessive dystrophic epidermolysis bullosa (RDEB), offering a t

PROMIS Measures Proven Valid and Responsive for Assessing the Multidimensional Impact of Chronic Skin Diseases
Dermatologydermatologypatient-reported outcomes

PROMIS Measures Proven Valid and Responsive for Assessing the Multidimensional Impact of Chronic Skin Diseases

By MedXY|Dec 23, 2025

A cohort study validates PROMIS measures for anxiety, depression, and social impact in chronic skin diseases, demonstrating that these standardized tools are reliable for tracking physical and social outcomes in clinical dermatology setting

Patient-Centered Insights: Understanding Treatment Preferences in Chronic Urticaria Management
Allergy & Immunologydermatologypatient preferences

Patient-Centered Insights: Understanding Treatment Preferences in Chronic Urticaria Management

By MedXY|Oct 8, 2025

This systematic review highlights patient and caregiver priorities in chronic urticaria treatment, emphasizing rapid symptom relief, long-term effectiveness, and safety.

Australian Dermatologists’ Perspectives on AI Integration: Trust, Benefits, and Barriers in Clinical Practice
Clinical Updatesartificial intelligencedermatology

Australian Dermatologists’ Perspectives on AI Integration: Trust, Benefits, and Barriers in Clinical Practice

By MedXY|Oct 9, 2025

A recent survey reveals that Australian dermatologists are cautiously integrating AI into practice, prioritizing accuracy and trust for diagnostic use, with optimism about AI enhancing patient access and reducing workload but concerns about

Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa
Dermatologyanxietydepression

Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa

By MedXY|Oct 6, 2025

Patients with hidradenitis suppurativa face a higher risk of first-time depression and anxiety, regardless of disease severity, highlighting the need for comprehensive psychiatric care.

Revolutionizing Wound Healing Assessment: The Role of LC-OCT and AI
AIartificial intelligencedermatology

Revolutionizing Wound Healing Assessment: The Role of LC-OCT and AI

By MedXY|Oct 2, 2025

This study explores the integration of line-field confocal optical coherence tomography (LC-OCT) with artificial intelligence (AI) to enhance wound healing evaluations, providing deeper insights into clinical interventions.

Scrotal Eczema: Understanding, Treating, and Preventing This Common Yet Distressing Condition
Dermatologydermatologyskin health

Scrotal Eczema: Understanding, Treating, and Preventing This Common Yet Distressing Condition

By MedXY|Dec 25, 2025

Scrotal eczema causes significant discomfort but can be effectively managed with the right care. Learn about causes, treatments, and tips to prevent flare-ups.

Hair Transplantation: Is It a Permanent Solution for Hair Loss?
Dermatologydermatologyhair transplant

Hair Transplantation: Is It a Permanent Solution for Hair Loss?

By MedXY|Dec 25, 2025

Exploring whether hair transplantation truly offers a permanent fix for hair loss, this article examines scientific evidence, common myths, and practical advice for those considering the procedure.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities